FT : Crude rally stalls after IEA forecasts oil surplus

Crude rally stalls after IEA forecasts oil surplus
Brent prices slip as watchdog predicts slowing demand growth in 2024

A week-long rally in crude oil, driven by a supply shortfall, eased on Tuesday as the west’s energy watchdog forecast that global inventories would grow next year.

The International Energy Agency predicted that growth in demand for crude would soften as the summer US driving season ended in coming weeks, and be further covered when planned production increases hit the market later this year.

The cautious report helped cool crude prices after what the IEA described as “Olympic levels of volatility” in the past month.

Brent crude slipped 0.6 per cent to $81.78, having risen more than 7 per cent since the start of August, when it was caught up in broader market fears that the US was heading for a recession. WTI, the US equivalent that has also rallied, was also down 0.6 per cent, at $79.60.

The IEA’s monthly report showed that demand in the US helped push consumption growth to 870,000 barrels a day in the second quarter, countering a slowdown in China.

The IEA expects growth in demand to be covered by supply growth of about 1.5mn b/d this year and 2025, from non-Opec countries, such as US, Guyana, Canada and Brazil.

The predictions stand even if some Opec+ members extend the voluntary production cuts that have supported the price of crude for more than a year. The cuts, led by Saudi Arabia and Russia, are due to unwind from the fourth quarter.

“Despite the marked slowdown in Chinese oil demand growth, Opec+ has yet to call time on its plan to gradually unwind voluntary production cuts starting in the fourth quarter,” said the IEA, which is primarily funded by members of the OECD.

The agency added that current balances suggested that even if the Opec+ cuts remained in place, global inventories could grow by an average 860,000 b/d in 2025 as other producers kept pumping oil, which would “more than cover expected demand growth”.

For the year, the IEA expects global demand to increase by just under 1mn b/d, less than the 2.1mn b/d estimate of the producer cartel Opec, and to grow by a similar level in 2025.

Oil prices have been struggling to break through their ranges this year, with crude averaging about $83 a barrel, as forecasts of weakening demand were countered by tensions in the Middle East and production cuts.

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Atea Pharmaceuticals (AVIR) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $6.88
    • Dell (DELL) upgraded to Equal Weight from Underweight at Barclays; tgt $97
    • Ducommun (DCO) upgraded to Buy from Neutral at Goldman; tgt raised to $80
    • First Industrial Realty (FR) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $64
  • Downgrades:
    • Academy Sports + Outdoors (ASO) downgraded to Hold from Buy at TD Cowen; tgt lowered to $54
    • CenterPoint (CNP) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $28
    • Cytokinetics (CYTK) downgraded to Neutral from Buy at Goldman; tgt lowered to $60
    • Danimer Scientific (DNMR) downgraded to Hold from Buy at TD Cowen; tgt lowered to $1
  • Others:
    • Artiva Biotherapeutics (ARTV) initiated with a Buy at Needham; tgt $23
    • Artiva Biotherapeutics (ARTV) initiated with an Outperform at Wedbush; tgt $18
    • Artiva Biotherapeutics (ARTV) initiated with a Buy at TD Cowen
    • Artiva Biotherapeutics (ARTV) initiated with an Overweight at Cantor Fitzgerald; tgt $23
    • Artiva Biotherapeutics (ARTV) initiated with a Buy at Jefferies; tgt $21
    • Cintas (CTAS) initiated with an Underweight at Wells Fargo; tgt $735
    • Ecolab (ECL) initiated with an Overweight at Wells Fargo; tgt $270
    • Equifax (EFX) initiated with an Overweight at Wells Fargo; tgt $340
    • FactSet (FDS) initiated with an Equal Weight at Wells Fargo; tgt $435
    • Fair Isaac (FICO) initiated with an Overweight at Wells Fargo; tgt $2100
    • Hormel Foods (HRL) upgraded to Buy from Neutral at Citigroup; tgt raised to $37
    • Inozyme Pharma (INZY) resumed with a Buy at Jefferies; tgt raised to $17

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • TME -6.9%, ONON -6.5%, HBM -4.3%, MRSN -3.5%, KGS -2.7%, HD -2.4%, SLF -2%, DHT -1.2%, SE -1.2%, CATX -0.9%
Other news:
  • SYRS -64.9% (provides update on SELECT-AML-1 Phase 2 Clinical Trial)
  • RILY -10.8% (to delay 10-Q filing)
  • RXO -5.1% (private placement)
  • WES -3.8% (prices secondary offering of common units for gross proceeds of $685.9 mln)
  • AHR -3.7% (files mixed shelf and stock offering)
  • SCNI -3.2% (loan restructuring agreement with European Investment Bank; converting approximately $29 million of debt to preferred equity convertible into 19.5% common equity)
  • JBLU -2.9% (prices offering of $400 mln of 2.50% convertible senior notes due 2029)
  • FRST -2.3% (to delay 10-Q filing)
  • UTZ -2.1% (Completes Acquisition of Strategic Distribution Rights of National Food Corp)
  • ARDX -2.1% (detailed Commercial Supply Agreement with Catalent Pharma)
  • SLF -2% (to renew NCIB to repurchase 15 mln shares)
  • INO -1.9% (entered into $60 mln Equity Distribution Agreement with Oppenheimer)
  • OXY -1.7% (stock offering)
  • VCTR -1.6% (reports total AUM)
  • QSR -1.2% (prices secondary offering)
Analyst comments:
  • ASO -1.2% (downgraded to Hold from Buy at TD Cowen)
  • CYTK -1.1% (downgraded to Neutral from Buy at Goldman)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • HUYA +9.2%, PSFE +9.2%, PACS +8.3%, SRAD +6.3%, RUM +3.8% (also partnering with Miami Dolphins), WULF +3.6%, KYTX +3.4%
Other news:
  • GCTS +12.8% (Signs MOU with Samsung (SSNLF) for development of 4G/5G Chipsets and Modules)
  • STXS +6.7% (submits 510(k) in the U.S.)
  • SGML +2.4% (FY operations update)
  • MARA +1% (prices oversubscribed offering of $250 mln of 2.125% convertible senior notes due 2031)
  • SNDL +1% (remaining minority interest of Nova Cannabis; to execute arrangement agreement with key shareholder support)
Analyst comments:
  • DELL +1.6% (upgraded to Equal Weight from Underweight at Barclays)

WSJ : Market Volatility Is Back. Will It Last?

Market Volatility Is Back. Will It Last?
Investors are buckling up for more turbulence after last week’s global drama interrupted an unusually calm period

Volatility is back in the stock market after a roughly 18-month slumber.

Turbulence has mounted since mid-July, culminating last week with the S&P 500 logging both its best and worst days since 2022. Traders have wound down some investments that thrived in calm conditions and pulled back from bets that the sideways action would persist.

The signs are unmistakable: A once-in-a-generation rout in Japanese stocks. Half-trillion-dollar daily swings in value of the Magnificent 7 group of tech giants. A streak of seesawing Nasdaq Composite sessions last seen during the depths of the pandemic.

Now, for investors big and small, the question is: Will it continue?

“When you’re low for so long, you’re bound to have a pickup,” said Eric Metz, chief investment officer at SpiderRock Advisors, referring to daily swings in asset prices. “When it changes, it changes fast.”

The jolt marks the start of a more anxious phase for a record-breaking market that has methodically boosted Americans’ wealth and propped up the consumer spending that is central to the U.S. economy. As investors parse each jobs report or corporate earnings release for clues about what could drive equities’ next move, many of the factors behind their unusual lull in recent months are increasingly in question.

Wall Street is growing more skeptical about the payoffs of artificial intelligence, fueling a potentially massive rotation into other stocks and threatening to derail indexes that have become top-heavy with tech shares. A weakening U.S. labor market has rekindled economic fears. The inflation-fighting Federal Reserve in September is expected to begin interest-rate cuts that could reroute the global flow of capital.

While stocks took a breather Monday after last week’s whirlwind, new sources of potential choppiness will land on trading desks this week. An inflation report Wednesday, followed by retail-sales data Thursday, should provide hints about whether the Fed will slash rates by a quarter-point next month as many investors anticipate.

Disappointing readouts could draw speculation of a half-point cut and push investors to flee riskier assets for the safety of government bonds. Earlier this month, after the Labor Department reported less hiring in July than economists forecast, yields on 10-year and 30-year Treasurys tumbled to their steepest weekly declines since the Covid-19-induced free fall.

In the now-jittery market, TD Securities wrote to clients, even “mundane economic surprises could drive outsized market moves.”

Last Thursday, the tech-heavy Nasdaq finished an eight-day stretch in which it rose or fell by at least 1%, with momentum sometimes reversing mid-session. The tech-heavy index has faced longer streaks of such volatility just three times the past two decades, according to Dow Jones Market Data, once in March 2020 and twice during the 2008 financial crisis.

So far, the recent froth has done relatively little harm to individual investors who have watched their retirement and brokerage accounts steadily balloon. Although the S&P 500 is down 5.7% from its July peak, the index remains 12% higher than the start of the year.

But the gyrations can be more painful for trading firms that bet on asset prices, often with borrowed money. The risk is that their rush to reduce risk or capitalize on momentum can reverberate across markets.

That is what happened after the Bank of Japan raised its benchmark interest rate, pushing up the value of the yen from some its lowest levels in decades. The move blew up leveraged bets on the currency staying weak, which some analysts say totaled $1 trillion in size, and forced investors to unload other holdings to compensate.

The resulting deleveraging slammed stocks on Aug. 5, with Japan’s Nikkei 225 index suffering its worst one-day loss since 1987 before bouncing back somewhat later last week. In the U.S., the Cboe Volatility Index—known as Wall Street’s fear gauge—momentarily spiked to its largest intraday gain on record.

“If you were on the wrong side [of a move], you were really wrong,” said Jonathan Corpina, senior managing partner at Meridian Equity Partners.

Corpina and others say the tumult could ultimately be healthy if investors reduced risk in a big way. “Let it all flush out, let everybody panic,” he said. “You should actually be buying at these opportunities.”

But any such moves will also play out against a changing economic backdrop. After a year of relatively stable monetary policy, central bankers in the U.S. and Europe could slash borrowing costs at potentially different speeds. Their counterparts in Japan, where inflation is accelerating for the first time in years, might raise rates further.

The range of potential outcomes has contributed to a pullback from at least one popular bet that volatility will remain low. According to Morningstar Direct, investors this year added an average of $556 million a week into U.S.-based derivative-income exchange-traded funds, which sell options contracts on stocks held in the fund to juice returns. Net flows into those products plunged to about $117 million last week.

Underlying measures of volatility retreated Monday after the previous weekend’s rush for the exits didn’t repeat itself. Still, in a market where a handful of AI-focused tech giants command huge sway over stock indexes, some investors remain wary.

Double-digit declines over the past month by shares in five of the Magnificent Seven companies have raised the stakes for Nvidia’s earnings report later in August. Shares in the artificial-intelligence poster child have gained or lost at least 5% in six of the past 10 trading sessions.

“People think the panic is over and are loading back up,” said Peter Tchir, head of macro strategy at Academy Securities. “I don’t think that we’ve tasted the panic yet.”

>>> Europe : Brokers Upgrades & Downgrades - 13th of August 2024 V2(+)

* Bridgepoint Raised to Overweight at JPMorgan; PT 358 pence
* Exasol Raised to Buy at Hauck & Aufhaeuser; PT 3.10 euros (+)
* FLEX LNG Raised to Buy at Arctic Securities; PT 325 kroner
* GTT Raised to Buy at Berenberg
* Hannover Re Raised to Buy at Berenberg; PT 260 euros
* Odfjell Raised to Buy at Norne Securities; PT 200 kroner (+)
* Salmar Raised to Buy at ABG; PT 753 kroner

>>> Down
* Antin Cut to Neutral at JPMorgan; PT 14.90 euros
* Endomines Finland Cut to Sell at Inderes; PT 7.30 euros
* KH Group Oyj Cut to Reduce at Inderes; PT 60 euro cents
* Legal & General Cut to Add at AlphaValue/Baader
* Maha Cut to Neutral at SpareBank; PT 8 kronor (+)
* Spirax Cut to Hold at Peel Hunt; PT 8,300 pence
* Stora Enso Cut to Neutral at JPMorgan; PT 14 euros
* ZoomInfo Cut to Neutral at Daiwa; PT $9

>>> Initiation
* Danske Bank Reinstated Overweight at Morgan Stanley
* Devyser Diagnostics Rated New Buy at Nordea; PT 125 kronor
* Galderma Rated New Outperform at RBC; PT 89 Swiss francs
* Lottomatica Rated New Buy at Berenberg; PT 16.20 euros
* Uniqa Rated New Buy at AlphaValue/Baader

>>> Call
* Danske Bank Overweight at Morgan Stanley on Capital Distribution
* Dowlais May Suffer Sharp Fall on Weak Guidance: Jefferies (+)
* GTT Back to Buy at Berenberg, Pullback in Shares Is Overdone
* Hannover Re Valuation Undemanding, Raised to Buy at Berenberg
* Lottomatica Gets Buy Rating, Street-High Target at Berenberg (+)

>>> Stoxx 600 Pre-Market Indications

  • Kongsberg (KOZ TH) +1.8%
  • Salmar (JEP TH) +1.3%
    • Salmar Raised to Buy at ABG; PT 753 kroner
  • Rio Tinto (RIO1 TH) +1.2%
  • UPM-Kymmene (RPL TH) +1.1%
  • TAG Immobilien (TEG TH) -1%
    • TAG Immobilien 1H FFO Misses Estimates
  • Grifols (OZTA TH) -1.4%
  • Brenntag (BNR TH) -2%
    • Brenntag 2Q Essentials Operating Gross Profit Beats Estimates

>>> TradeGate Pre-Market Indications

DAX:
  • Brenntag (BNR TH) -1.8%
    • Brenntag 2Q Essentials Operating Gross Profit Beats Estimates
MDAX:
  • HelloFresh (HFG TH) +8.7%
    • HelloFresh 2Q Adjusted Ebitda Beats Estimates
  • Evotec SE (EVT TH) +3.5%
  • Bilfinger (GBF TH) +2.5%
    • Bilfinger 2Q Adjusted Ebita EU70M Vs. EU43M Y/y
SDAX:
  • Mutares (MUX TH) +3.8%
  • Medios (ILM1 TH) +2.6%
  • MLP (MLP TH) +1.7%
  • RENK Group AG (R3NK TH) +1.4%
  • Thyssenkrupp Nucera AG & Co KGaa (NCH2 TH) +1.3%